OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Chikungunya: risks for travellers
Fabrice Simon, Éric Caumes, Tomáš Jelı́nek, et al.
Journal of Travel Medicine (2023) Vol. 30, Iss. 2
Open Access | Times Cited: 35
Fabrice Simon, Éric Caumes, Tomáš Jelı́nek, et al.
Journal of Travel Medicine (2023) Vol. 30, Iss. 2
Open Access | Times Cited: 35
Showing 1-25 of 35 citing articles:
Chikungunya seroprevalence, force of infection, and prevalence of chronic disability after infection in endemic and epidemic settings: a systematic review, meta-analysis, and modelling study
Hyolim Kang, Megan Auzenbergs, Hannah Clapham, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 5, pp. 488-503
Open Access | Times Cited: 22
Hyolim Kang, Megan Auzenbergs, Hannah Clapham, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 5, pp. 488-503
Open Access | Times Cited: 22
Chikungunya virus vaccine: a decade of progress solving epidemiological dilemma, emerging concepts, and immunological interventions
Mohd Sayeed Shaikh, Md. Faiyazuddin, Mubasshera Sabir Khan, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 9
Mohd Sayeed Shaikh, Md. Faiyazuddin, Mubasshera Sabir Khan, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 9
Progress in the molecular epidemiology of Chikungunya Virus
Duo Zhang, Zhiquan Qiu, Yujia Hao, et al.
Animals and zoonoses. (2025)
Open Access | Times Cited: 1
Duo Zhang, Zhiquan Qiu, Yujia Hao, et al.
Animals and zoonoses. (2025)
Open Access | Times Cited: 1
Chikungunya virus virus-like particle vaccine safety and immunogenicity in adults older than 65 years: a phase 3, randomised, double-blind, placebo-controlled trial
Lauren C. Tindale, Jason S. Richardson, Deborah M. Anderson, et al.
The Lancet (2025)
Closed Access | Times Cited: 1
Lauren C. Tindale, Jason S. Richardson, Deborah M. Anderson, et al.
The Lancet (2025)
Closed Access | Times Cited: 1
A randomized, double-blinded Phase 3 study to demonstrate lot-to-lot consistency and to confirm immunogenicity and safety of the live-attenuated chikungunya virus vaccine candidate VLA1553 in healthy adults
Robert P. McMahon, Ulrike Fuchs, Martina Schneider, et al.
Journal of Travel Medicine (2023) Vol. 31, Iss. 2
Open Access | Times Cited: 21
Robert P. McMahon, Ulrike Fuchs, Martina Schneider, et al.
Journal of Travel Medicine (2023) Vol. 31, Iss. 2
Open Access | Times Cited: 21
Chikungunya infection in returned travellers: results from the GeoSentinel network, 2005–2020
Rachel Bierbrier, Émilie Javelle, Francesca Norman, et al.
Journal of Travel Medicine (2024) Vol. 31, Iss. 2
Open Access | Times Cited: 8
Rachel Bierbrier, Émilie Javelle, Francesca Norman, et al.
Journal of Travel Medicine (2024) Vol. 31, Iss. 2
Open Access | Times Cited: 8
Novel chikungunya and dengue vaccines: travel medicine applications
Robert Steffen, Davidson H. Hamer, Lin H. Chen, et al.
Journal of Travel Medicine (2024) Vol. 31, Iss. 4
Closed Access | Times Cited: 8
Robert Steffen, Davidson H. Hamer, Lin H. Chen, et al.
Journal of Travel Medicine (2024) Vol. 31, Iss. 4
Closed Access | Times Cited: 8
Safety and immunogenicity of a live-attenuated chikungunya virus vaccine in endemic areas of Brazil: interim results of a double-blind, randomised, placebo-controlled phase 3 trial in adolescents
Vera Buerger, Sandra Hadl, Martina Schneider, et al.
The Lancet Infectious Diseases (2024)
Closed Access | Times Cited: 6
Vera Buerger, Sandra Hadl, Martina Schneider, et al.
The Lancet Infectious Diseases (2024)
Closed Access | Times Cited: 6
From bench to clinic: the development of VLA1553/IXCHIQ, a live-attenuated chikungunya vaccine
Lin H. Chen, Andrea Fritzer, Romana Hochreiter, et al.
Journal of Travel Medicine (2024)
Open Access | Times Cited: 6
Lin H. Chen, Andrea Fritzer, Romana Hochreiter, et al.
Journal of Travel Medicine (2024)
Open Access | Times Cited: 6
Innovative strategies and challenges mosquito-borne disease control amidst climate change
Yuan Zhang, Minhao Wang, Mingxia Huang, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 6
Yuan Zhang, Minhao Wang, Mingxia Huang, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 6
Combined immunogenicity evaluation for a new single-dose live-attenuated chikungunya vaccine
Vera Buerger, Gerald Maurer, Karin Kosulin, et al.
Journal of Travel Medicine (2024) Vol. 31, Iss. 7
Closed Access | Times Cited: 5
Vera Buerger, Gerald Maurer, Karin Kosulin, et al.
Journal of Travel Medicine (2024) Vol. 31, Iss. 7
Closed Access | Times Cited: 5
Vaccine value profile for Chikungunya
Ximena Flandes, Clairissa A. Hansen, Sunil Palani, et al.
Vaccine (2023) Vol. 42, Iss. 19, pp. S9-S24
Open Access | Times Cited: 12
Ximena Flandes, Clairissa A. Hansen, Sunil Palani, et al.
Vaccine (2023) Vol. 42, Iss. 19, pp. S9-S24
Open Access | Times Cited: 12
Vaccines for International Travelers: Current Status and Recent Developments
Henry W. Murray
The American Journal of Medicine (2025)
Closed Access
Henry W. Murray
The American Journal of Medicine (2025)
Closed Access
Polish travellers on the move: a study of knowledge of travel health and associated practices among Polish travellers abroad
Anna Bogacka, Agnieszka Wroczyńska, Maciej Grzybek
Travel Medicine and Infectious Disease (2025), pp. 102842-102842
Open Access
Anna Bogacka, Agnieszka Wroczyńska, Maciej Grzybek
Travel Medicine and Infectious Disease (2025), pp. 102842-102842
Open Access
A brief overview of chikungunya-related pain
William Antônio Gonçalves, Carla Daiane Ferreira de Sousa, Mauro Martins Teixeira, et al.
European Journal of Pharmacology (2025), pp. 177322-177322
Closed Access
William Antônio Gonçalves, Carla Daiane Ferreira de Sousa, Mauro Martins Teixeira, et al.
European Journal of Pharmacology (2025), pp. 177322-177322
Closed Access
Severe Infections in Returning Travelers
Cayleigh Blumrick
Medical Clinics of North America (2025) Vol. 109, Iss. 3, pp. 695-704
Closed Access
Cayleigh Blumrick
Medical Clinics of North America (2025) Vol. 109, Iss. 3, pp. 695-704
Closed Access
Cross-neutralizing activity of the chikungunya vaccine VLA1553 against three prevalent chikungunya lineages
Karin Kosulin, Trevor Brasel, Jeanon N. Smith, et al.
Emerging Microbes & Infections (2025)
Open Access
Karin Kosulin, Trevor Brasel, Jeanon N. Smith, et al.
Emerging Microbes & Infections (2025)
Open Access
Reiseimpfungen – Hinweise und Empfehlungen
Camilla Rothe, Deike Rosenbusch, Silja Bühler, et al.
Flugmedizin · Tropenmedizin · Reisemedizin - FTR (2025) Vol. 32, Iss. 02, pp. 68-98
Closed Access
Camilla Rothe, Deike Rosenbusch, Silja Bühler, et al.
Flugmedizin · Tropenmedizin · Reisemedizin - FTR (2025) Vol. 32, Iss. 02, pp. 68-98
Closed Access
Heterozygous Interferon Signaling Deficient Mice as Animal Models for Chikungunya Virus Infection in the Heart
Shazeed-Ul Karim, Farzana Nazneen, Prince M.D. D, et al.
Research Square (Research Square) (2025)
Closed Access
Shazeed-Ul Karim, Farzana Nazneen, Prince M.D. D, et al.
Research Square (Research Square) (2025)
Closed Access
Systemic and Ocular Manifestations of Arboviral Infections: A Review
Moncef Khairallah, Nesrine Abroug, Derrick P. Smit, et al.
Ocular Immunology and Inflammation (2024) Vol. 32, Iss. 9, pp. 2190-2208
Closed Access | Times Cited: 3
Moncef Khairallah, Nesrine Abroug, Derrick P. Smit, et al.
Ocular Immunology and Inflammation (2024) Vol. 32, Iss. 9, pp. 2190-2208
Closed Access | Times Cited: 3
Mucocutaneous manifestations of chikungunya fever: an update
Keshavamurthy Vinay, Anish Thind, Hitaishi Mehta, et al.
International Journal of Dermatology (2023) Vol. 62, Iss. 12, pp. 1475-1484
Closed Access | Times Cited: 7
Keshavamurthy Vinay, Anish Thind, Hitaishi Mehta, et al.
International Journal of Dermatology (2023) Vol. 62, Iss. 12, pp. 1475-1484
Closed Access | Times Cited: 7
Determining force of infection for chikungunya to support vaccine policy development
Annika Beate Wilder-Smith, Annelies Wilder‐Smith
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 5, pp. 441-442
Closed Access | Times Cited: 2
Annika Beate Wilder-Smith, Annelies Wilder‐Smith
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 5, pp. 441-442
Closed Access | Times Cited: 2
Current diagnostics and biomarkers for arboviral infections (a review on Dengue, Zika, West Nile and Chikungunya viruses)
Hafeez Aderinsayo Adekola, Kareem A. Wahab, Omotayo E. Odunsi, et al.
Problems of Virology (2024) Vol. 69, Iss. 1, pp. 31-41
Open Access | Times Cited: 2
Hafeez Aderinsayo Adekola, Kareem A. Wahab, Omotayo E. Odunsi, et al.
Problems of Virology (2024) Vol. 69, Iss. 1, pp. 31-41
Open Access | Times Cited: 2
Molecular and serological evidence of chikungunya virus infection with high case fatality among pediatric population with acute encephalitis syndrome: first report from Eastern Uttar Pradesh, India
Pooja Bhardwaj, Kamlesh Kumar Sah, Vishal Yadav, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2024) Vol. 43, Iss. 6, pp. 1205-1212
Closed Access | Times Cited: 2
Pooja Bhardwaj, Kamlesh Kumar Sah, Vishal Yadav, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2024) Vol. 43, Iss. 6, pp. 1205-1212
Closed Access | Times Cited: 2
The current status of arboviruses with major epidemiological significance in Europe
Fernando Calle, Marta Arsuaga, Graciela Rodríguez-Sevilla, et al.
Enfermedades Infecciosas y Microbiología Clínica (2024)
Open Access | Times Cited: 2
Fernando Calle, Marta Arsuaga, Graciela Rodríguez-Sevilla, et al.
Enfermedades Infecciosas y Microbiología Clínica (2024)
Open Access | Times Cited: 2
